Abivax |

Biotechnology · Immunology & Inflammation Therapeutics
Has an LEI
Data updated Nov 20, 2026Full reportReport a mistake
Lately:7 news stories in 90 daysFollow changes →

Facts

as of Nov 20, 2026

Abivax is a clinical-stage biotechnology company driven to advance human health by regulating the immune response through the power of microRNA.

Legal name
ABIVAXactive
Headquarters
Paris, France
Founded
2013
Employees
20–49French register · Dec 2023
Register numbers
SIREN 799363718
Website
abivax.com

These are the key facts about Abivax | on Alion as of Nov 20, 2026. Abivax | is headquartered in Paris, France. It was founded in 2013.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

People

20–49EmployeesFrench register · Dec 2023

Products

top 6%Web presenceof 133.2M domains by links, Common Crawl

Abivax |: 33 research papers in five years.

Legal entity active
ABIVAX
Yes
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Patents
35
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Sources: the outlets named on each headline, each story once

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Paris FranceHeadquarters0
Source: office addresses in postings and company registers